Nychas E^*, Marfil-Sánchez A^*, Chen X, Mirhakkak M, Li H, Jia Q, Xu A, Nielsen HB, Niewdorp M, Loomba R, Ni Y^#, Panagiotou G^# (2025) Discovery of robust and highly specific microbiome signatures of non-alcoholic fatty liver disease. Microbiome 13(1), 10.

Wang J, Qin Y, Wu Q, Zeng D, Gao X, Wang Q, Li Z, Ni Y^#, Li H, Zhang P, Guo J, Ma W, Maitusun M, Jin X, Chen M, Zhu L, Lu Q, Chen Q, Wu Y, Lin C, Han R, Cheng D, Ni J, Wang X, Yao F, Zhuang J, Xia J, Liu D, Lu Y, Kang P, Yu S, Chen A, Zhang Y, Li Q, Ge W, Long X, Jiang Z, Guan Z, Jin Z, Jin P, Li T, Shu J, Yang J, Wang J, Jiang N, Qian J, Jung Y, Zhang H, Yang Q, Ma L, Wu X, Huang X, Si D, Ren J, Qiao H, Guo Y, Huang Z, Wang W, Deng W, Bi L, Zhao D, Li Y, Lau RWH, Tham YC, Ma X, Ma J, Shen D, Zhang S, Guan H, Zou W, Guo M, Guan X, Yang X, Xu A, Wu J, Panagiotou G^#, Tse MA, Kim J, Wu E, Thalmann D, Magnenat Thalmann N, Fregni F, Wong TY, Jia W, Zeng R, Lim CT, Sheng B, Li H (2025) An adaptive AI-based virtual reality sports system for adolescents with excess body weight: a randomized controlled trial Nature Medicine [Epub ahead of print]

Xu LL, McIlroy SE, Ni Y, Guibert I, Chen J, Rocha U, Baker DM^#, Panagiotou G^# (2025) Chemical pollution drives taxonomic and functional shifts in marine sediment 2 microbiome, influencing benthic metazoans. ISME Comm 5(1), ycae141.

Li H^*, Zhang L^*, Li J^*, Wu Q^*, Qian L, He J, Ni Y, Kovatcheva-Datchary P, Yuan R, Liu S, Shen L, Zhang M, Sheng B, Li P, Kang K, Wu L, Fang Q, Long X, Liu X, Wang X, Li Y, Ye Y, Ye J, Bao Y, Zhao Y, Xu G, Panagiotou G^#, Xu A^#, and Jia W^# (2024) Resistant starch intake facilitates weight loss in humans by reshaping the gut microbiota. Nat Metab 6(3), 578-597.

Wang Y^*, Chen J^*, Ni Y, Liu Y, Gao X, Tse MA, Panagiotou G^#, Xu A^# (2024) Exercise-changed gut mycobiome as a potential contributor to metabolic benefits in diabetes prevention: an integrative multi-omics study Gut Microbes 16(1), 2416928.

Chen J^*, Leal Siliceo S^*, Ni Y, Nielsen HB, Xu A, Panagiotou G (2023) Identification of robust and generalizable biomarkers for microbiome-based stratification in lifestyle interventions. Microbiome 11(1), 178.

Leung H, Xiong L, Ni Y, Busch A, Bauer M, Press AT, Panagiotou G (2023) Impaired flux of bile acids from the liver to the gut reveals microbiome-immune interactions associated with liver damage. NPJ Biofilms and microbiomes 9(1), 35.

Mirhakkak MH^*, Chen X^*, Heinekamp T, Sae-Ong T, Xu LL, Ni Y, Kurzai O, Barber AE, Brakhage AA, Boutin S, Schäuble S^#, Panagiotou G^# (2023) Genome-scale Metabolic modeling of Aspergillus fumigatus strains reveals growth dependencies on the lung microbiome. Nat Commun 14(1), 4369.

Ni Y^*, Qian L^*, Leal Siliceo S^*, Long X^*, Nychas E, Liu Y, Ismaiah MJ, Leung H, Zhang L, Gao Q, Wu Q, Zhang Y, Jia Xi, Liu S, Yuan R, Zhou L, Wang X, Li Q, Zhao Y, El-Nezami H, Xu A, Xu G^#, Li H^#, Panagiotou G^#, Jia W^# (2023) Resistant starch decreases intrahepatic triglycerides in NAFLD patients via gut microbiome alterations. Cell Metab 35(9), 1530-1547.

Leung H, Long X, Ni Y, Qian L, Nychas E, Siliceo SL, Pohl D, Hanhineva K, Liu Y, Xu A, Nielsen HB, Belda E, Clément K, Loomba R, Li H, Jia W, Panagiotou G (2022) Risk assessment with gut microbiome and metabolite markers in NAFLD development. Sci Transl Med 14(648), eabk0855.